Boston Scientific (BSX) PT Raised to $92 at Morgan Stanley
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts BSX Hot Sheet
Price: $46.03 +5.82%
Rating Summary:
28 Buy, 14 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Rating Summary:
28 Buy, 14 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Join SI Premium – FREE
Morgan Stanley analyst Patrick Wood raised the price target on Boston Scientific (NYSE: BSX) to $92.00 (from $79.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Increasing unusual call option volume: BSX SGHC USAS SYF INO CHGG EVGO REAL ITB MNRO KMX MSOS SGI PGY HNST GMAB
- Datadog (DDOG) PT Lowered to $285 at Rosenblatt
- United Therapeutics Corp. (UTHR) PT Raised to $720 at Raymond James
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
